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Abstract
Translation elongation factor P (EF-P) in Bacillus subtilis is required for a form of surface 
migration called swarming motility. Furthermore, B. subtilis EF-P is post-translationally modified 
with a 5-aminopentanol group but the pathway necessary for the synthesis and ligation of the 
modification is unknown. Here we determine that the protein YmfI catalyzes the reduction of EF-
P-5 aminopentanone to EF-P-5 aminopentanol. In the absence of YmfI, accumulation of 5-
aminopentanonylated EF-P is inhibitory to swarming motility. Suppressor mutations that enhanced 
swarming in the absence of YmfI were found at two positions on EF-P, including one that changed 
the conserved modification site (Lys 32) and abolished post-translational modification. Thus, 
while modification of EF-P is thought to be essential for EF-P activity, here we show that in some 
cases it can dispensable. YmfI is the first protein identified in the pathway leading to EF-P 
modification in B. subtilis, and B. subtilis encodes the first EF-P ortholog that retains function in 
the absence of modification.
Keywords
YmfI; EF-P; translation; post-translational modification; swarming motility
INTRODUCTION
The protein Elongation Factor P (EF-P) is a translation elongation factor highly conserved in 
all living things (eIF-5a in Eurkayotes and aIF-5a in Archaea) (Ganoza, 2002, Lassak, 2016, 
and Rajkovic, 2017). Recent work has shown that EF-P enhances translation of particular 
codon combinations encoding prolines in both Bacteria and Eukaryotes (Doerfel, 2013, Ude, 
2013, and Gutierrez, 2013). The mechanism by which EF-P potentiates translation is poorly 
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understood but EF-P structurally resembles a tRNA molecule, has been shown to bind 
between the E and P sites of the ribosome, and may function catalytically by increasing 
entropy (Blaha, 2009, Hanawa-Suetsugu, 2004, Doerfel. 2015 and Schmidt, 2016). In nearly 
all systems studied to date, depletion of EF-P is either lethal or results in severe growth 
limitation, presumably due to the impaired ability to translate target sequences in essential 
genes (Balibar, 2013, Patel, 2009, Schnier, 1991, and Yanagisawa, 2016). The one exception 
thus far is the Gram positive firmicute bacterium Bacillus subtilis where EF-P is not required 
for growth and is instead specifically required for swarming motility, a flagellar-mediated 
multicellular behavior in which cells rapidly move across a semi-solid surface (Kearns, 
2004; Rajkovic, 2016).
In all organisms tested to date, EF-P is post-translationally modified on a conserved lysine/
arginine residue at a position analogous to the amino acid acceptor site of tRNAs (Katz, 
2013). The chemical nature of the EF-P post-translational modification varies between 
species. Within the proteobacteria, Escherichia coli and Salmonella enterica modify EF-P 
lysine 34 with a β-lysine group (Blaha, 2010 and Navarre, 2010), whereas Neisseria 
meningitidis, Pseudomonas aeruginosa and Shewanella oneidensis modify EF-P arginine 32 
with a rhamnose moiety (Lassak, 2015, Rajkovic, 2015, and Yanagisawa, 2016). The EF-P 
ortholog in Eukaryotes, eIF5A, is modified by the addition of hypusine (Cooper, 1983). In 
each case mentioned thus far the function of the modification is thought to be essential for 
EF-P activity because mutations in the modification system result in growth defects similar 
to efp deletion mutants and reduce the translation rate of consecutive prolines (Patel, 2009, 
Sasaki, 1996, Yanagisawa, 2009, Doerfel et al., 2013, and Yanagisawa, 2015). The 
mechanism by which the various modification groups enhance EF-P activity is unknown.
B. subtilis modifies EF-P lysine 32 with yet another chemical variant, 5-aminopentanol. 
Substitution of the conserved modified lysine to alanine (EF-PK32A) was shown to impair 
surface motility but the enzymes required for 5-aminopentanolylation were unknown 
(Rajkovic, 2016). Here, we revisit the swarming mutants from the same screen that first 
discovered EF-P as a swarming motility activator and we identify YmfI as a protein required 
for EF-P 5-aminopentanolylation. YmfI is paralogous to the fatty acid biosynthesis gene 
FabG and catalyzes the reduction of 5-aminopentanone to 5-aminopentanol as, in the 
absence of YmfI, EF-P was modified with a 5-aminopentanone group and cells exhibit 
attenuated swarming motility. Finally, in a forward genetic screen, we identify mutations in 
efp that bypass the requirement for YmfI in swarming motility and in one of the mutants, 
EF-PK32R, post-translational modification was abolished. Thus, YmfI is the first example of 
an enzyme involved in EF-P modification in B. subtilis, and the B. subtilis EF-P is the first 
example that retains activity in the absence of modification.
RESULTS
The absence of YmfI impairs swarming motility
EF-P proteins are thought to be activated by post-translational modification and B. subtilis 
EF-P is post-translationally modified by a 5-aminopentanol group attached to lysine 32 
(Rajkovic, 2016). B. subtilis EF-P resolved as two bands in semi-native gel electrophoresis 
and Western blot analysis, and we hypothesized that the two bands could represent different 
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states of EF-P modification and/or activity (Fig 1A left, lane T0). To determine whether the 
two species of EF-P were differentiated by a post-translational mechanism, translation was 
inhibited by the addition of spectinomycin and EF-P electrophoretic mobility in semi-native 
gel electrophoresis was monitored over time. Within 15 minutes of inhibiting translation, the 
lower band species of EF-P diminished in abundance (Fig 1A left, lanes T0-T240). We 
hypothesize that the two bands of EF-P represent different post-translational modification 
states.
To find proteins involved in EF-P post-translational modification, whole cell lysates of 
transposon mutants taken from the same screen that identified the swarming motility defect 
of an efp mutant were resolved by semi-native gel electrophoresis and Western blot analysis 
(Kearns and Losick, 2004). Mutation of one gene, ymfI, resulted in a single species of EF-P 
(Fig 1B). When resolved side-by-side, EF-P of the ymfI mutant exhibited an electrophoretic 
mobility similar to the lower band found in the wild type (Fig 1C, compare lanes 1 and 2). 
Moreover, the band intensity of ymfI EF-P did not change over time after spectinomycin 
treatment (Fig 1A middle). We conclude that the protein encoded by the ymfI gene, YmfI, 
alters EF-P mobility in semi-native gels and we hypothesize that YmfI might control EF-P 
post-translational modification.
Whereas mutation of efp results in a severe defect in swarming motility, mutation of ymfI 
resulted in periodic cessation and reinitiation of swarming motility to create a terraced 
colony appearance on swarm plates (Fig 2A,B) (Kearns and Losick, 2004). The terracing 
pattern of swarming was reminiscent of an EF-P mutant defective in post-translation 
modification in which the modification site lysine 32 was mutated to an alanine (Fig 2A,C) 
(Rajkovic et al., 2016). In both qualitative and quantitative analyses, the swarming defect of 
the efpK32A mutant was more severe than that of a ymfI mutant (Fig 2A,C). Furthermore, the 
swarming motility of a ymfI efpK32A double mutant resembled that of the efpK32A mutant 
alone, suggesting that the efpK32A mutation was epistatic (Fig 2A,C). As further evidence of 
epistasis, Western blots of EF-P resolved by semi-native gel electrophoresis indicated an 
altered mobility of the mutant EF-PK32A protein that was not further altered by the absence 
of YmfI (Fig 1C, compare lanes 3 and 4). We conclude that YmfI requires EF-P lysine 
residue 32 to promote swarming motility and alter EF-P electrophoretic mobility.
YmfI is homologous to FabG, a 3-keto-acyl ACP reductase essential for fatty acid 
biosynthesis in E. coli, and contains conserved active site residues (Fig S1A) (Price, 2001). 
Whereas FabG is essential for growth, cells mutated for ymfI exhibited only a 5% decrease 
in growth rate resembling the slight growth rate reduction found in cells mutated for efp (Fig 
S2). To determine whether the YmfI active site residues are required for promoting 
swarming motility and altering EF-P semi-native gel mobility, we first complemented the 
ymfI mutation in trans. The ymfI gene appeared to be the third gene in a putative four gene 
operon (ymfFHIJ) (Fig 3A), and swarming motility was restored to the ymfI mutant when 
ymfI was cloned downstream of the PymfF promoter and inserted at an ectopic site in the 
chromosome (amyE∷PymfF-ymfI) (Fig 2D). Thus, the ymfI mutant defect was due to the 
absence of ymfI, not due to a polar effect on other genes in the operon which, when mutated, 
had no effect on swarming motility or EF-P native gel electrophoretic mobility (Fig S3A–E). 
The ectopic ymfI complementation construct did not restore swarming motility to the ymfI 
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mutant, however, when the ymfI putative active site residue tyrosine 150 was mutated to an 
alanine (amyE∷PymfF-ymfIY150A) (Fig 2D, Fig S1A). We conclude that the active site 
residue of YmfI is required for either YmfI activity or stability and we infer that YmfI may 
activate EF-P enzymatically.
To determine if YmfI directly participates in the alteration of EF-P electrophoretic mobility, 
recombinant YmfI was purified from E. coli and EF-P-FLAG was purified from the B. 
subtilis ymfI mutant (EF-P-FLAGymfI). EF-P-FLAGymfI resolved as a single band on semi-
native gel electrophoresis in the absence of YmfI or in the presence of YmfI but the absence 
of NADPH (Fig 1D, left and middle lanes). Upon incubation of EF-P-FLAGymfI in the 
presence of both purified YmfI and NADPH, however, a faint upper band resolved on semi-
native gel electrophoresis (Fig 1D, right lane). We conclude that YmfI is an enzyme that 
requires the NADPH cofactor and is sufficient in vitro to alter EF-P electrophoretic mobility 
on a semi-native gel.
YmfI is required for 5-aminopentanolylation of EF-P
One way in which YmfI might alter semi-native gel electrophoretic mobility in a manner 
dependent on its enzymatic activity is if YmfI is involved in 5-aminopentanolylation of EF-
P. In order to assess the modification status of EF-P, EF-P was affinity tagged and 
ectopically overexpressed from an IPTG-inducible promoter in efp and efp ymfI mutant 
backgrounds and subjected to chymotrypsin in-gel digestion. The digested protein was then 
resolved on an orbitrap elite mass spectrometer, and subjected to electron transfer 
dissociation fragmentation to generate a complete MS2 spectrum of the peptide containing 
Lys32 (QHVKPGKGAAF). In the wild type, both unmodified (Fig 4A, 1138.624 Da) and 5-
aminopentanolylated (Fig 4B, 1239.709 Da) EF-P peptides were detected. The additional 
mass of 101.085 Da is consistent with previous reports for 5-aminopentanol C5H12NO 
(Rajkovic et al., 2016). In the absence of YmfI, unmodified peptides were detected but 
instead of a 101.085 Da mass, a mass of 99.068 Da was identified on Lys32 (Fig 5). From 
the mass difference of 2 Da we determined that in the absence of YmfI, the post-
translational modification on Lys32 is C5H10NO. Although C5H10NO could represent 
multiple different structures, based on previous MS3 data of 5-aminopentanol and the 
proposed reductase activity of ymfI, we suggest it likely corresponds to 5-aminopentanone 
(Fig 4F). Further, while the precise position of the carbonyl can only be unequivocally 
determined with the use NMR or other high resolution structural methods, we suggest it 
likely corresponds to the position of the hydroxyl group in 5-aminopentanol at either the C3 
or C4 position (Rajkovic 2016).
Very low levels of 5-aminopentanolylated EF-P also appeared to be detected in the absence 
of ymfI (Fig 4E). As the reduced and oxidized forms differ by two hydrogen atoms, 
however, it is possible that the parent ion predicted to be the 5-aminopentanolylated peptide 
is in reality a heavy isotope of the 5-aminopentanonated peptide. In order to address this 
possibility, a predicted isotope distribution was calculated for QHVKPGKGAAF with either 
modification, and compared to the measured isotope distribution (Fig S4). Actual measured 
abundances for each isotope of the 5-aminopentanonated peptide in the ymfI background 
corresponded with predicted abundances precisely, but not for the 5-aminopentanolylated 
Hummels et al. Page 4
Mol Microbiol. Author manuscript; available in PMC 2018 October 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
peptide. Thus, the apparent 5-aminopentanolylated peptide in the ymfI mutant is likely an 
artifact of heavy isotope incorporation. Although the possibility that extremely low levels of 
5-aminopentanol exist in the absence of ymfI cannot be ruled out, the differences between 
the predicted and actual isotope distribution for 5-aminopentanolylated EF-P makes this 
possibility remote. We conclude that YmfI is an enzyme that directly catalyzes the reduction 
of 5-aminopentanone to 5-aminopentanol. We further conclude, based on YmfI’s ability to 
alter EF-P electrophoretic mobility in vitro, that YmfI alone is capable of catalyzing the 
reduction reaction when the substrate is ligated to EF-P.
During the mass spectrometry analyses, we noted that there appeared to be a relative excess 
of unmodified EF-P that did not seem consistent with the relative band intensity in the wild 
type (Compare Fig 1A left and Fig 4A,B). As the EF-P-FLAG construct was expressed from 
an IPTG-inducible promoter, we wondered whether 1 mM IPTG induction was causing 
over-representation of the unmodified form. Thus, an IPTG-titration was conducted for both 
the swarming motility phenotype and the semi-native gel Western blots. The Physpank-efp-
FLAG construct restored swarming motility to the efp mutant even in the absence of IPTG, 
suggesting that leakiness of the promoter was sufficient to rescue the phenotype (Fig 6A, 
upper) though EF-P protein was not detectable by Western blot analysis until 0.01 mM IPTG 
was added (Fig 6A, lower). Moreover, the EF-P upper band saturated in intensity while the 
lower band continued to accumulate (Fig 6A, lower). We conclude that the affinity-tagged 
version of EF-P is functional at very low levels in the efp mutant and that IPTG-induction 
resulted in hyper-accumulation of the unmodified form. In the efp ymfI double mutant, 
however, 0.03 mM IPTG induction of EF-P-FLAG was required to restore partial swarming 
(Compare first four lanes of Fig 6A,B upper). Further, 0.05 mM IPTG and greater allowed 
the efp ymfI double mutant to swarm at a faster rate than the ymfI mutant alone (Fig 6B, 
upper). Regardless, in the absence of YmfI, only one EF-P band was detected in Western 
blot analysis at all IPTG concentrations tested (Fig 6B, lower). We conclude that the efp 
ymfI double mutant requires more EF-P for swarming motility and that EF-P overexpression 
could partially suppress the absence of YmfI.
Modification independent alleles of EF-P bypass the need for YmfI
To explain the swarming defect of the ymfI mutant, we hypothesized that either the reduced 
5-aminopentanol modification was essential for EF-P activity, or the oxidized 5-
aminopentanone modification was inhibitory. To distinguish the two possibilities, we 
randomly mutagenized the efp gene and screened for mutations that bypass the need for 
YmfI. If the 5-aminopentanol group was essential for activity, we predicted that there would 
be no mutation in efp sufficient to bypass the absence of YmfI. To set up the screen, we first 
complemented the efp mutation in trans. The efp gene appears to be the third gene in a 
putative three gene operon (yqhS-papA-efp) (Fig S3F), and swarming motility was restored 
to the efp mutant when efp was cloned downstream of the PyqhS promoter region and 
inserted at an ectopic site in the chromosome (amyE∷PyqhS-efp) (Fig 2E). Thus the efp 
mutant defect was due to the absence of EF-P, not due to a polar effect on other genes in the 
region which, when mutated had no effect on swarming motility or on EF-P semi-native gel 
electrophoretic mobility (Fig S3E,G,H). The PyqhS-efp complementation construct, however, 
did not restore swarming to the efp ymfI double mutant (Fig 2F). The failure to complement 
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the swarming defect of efp ymfI similar to that of ymfI alone appeared to be due a reduced 
level of ectopic EF-P expression relative to that of the native locus (Fig 1E), consistent with 
the observation that ymfI rescue depends on EF-P levels (Fig 6B). We conclude that 
transcription of efp from PyqhS is sufficient under most conditions but additional promoters 
may be needed to amplify expression when ymfI is mutated. We note that the upstream 
PyqhR may contribute to EF-P expression as transcriptomics indicates that there is no 
transcriptional terminator between the yqhR and yqhS genes (Fig S3F) (Nicolas et al., 
2012). We conclude that, in the absence of YmfI, a threshold of EF-P protein level and thus 
activity is required to initiate swarming motility.
Next, the PyqhS-efp complementation construct was randomly mutagenized using an error 
prone polymerase in seven separate tubes and each PCR product was separately transformed 
into an efp ymfI double mutant background to generate seven parallel pools of 
transformants. Each pool of transformants was collected and spotted as a mixed population 
onto swarming motility agar. Cells initially grew as a tight colony in the center of the plate 
but, in each pool, motile cells emerged with a prolonged lag period and swarmed outward 
from the origin. One colony was isolated from each motile swarm and was confirmed to 
have restored swarming motility. Sequencing of the PyqhS-efp construct indicated that each 
isolate contained either a mutation of Lys29 to an asparagine (EF-PK29N) or a mutation of 
Lys32 to an arginine (EF-PK32R) (Table 1). In three swarming proficient isolates, K29N or 
K32R was the only mutation present (Fig 2G). Mutation of K32R was allele-specific for the 
rescue of swarming motility in an efp ymfI background as ectopic introduction of K32A was 
not sufficient (Fig 2H). Furthermore, neither ectopic integrant of K29N nor K32R exhibited 
increased protein levels relative to ectopic integrant of the wild type allele in otherwise wild 
type cells indicating that suppression was not simply due to increased stability or expression 
of the mutant proteins (Fig 1E). We conclude that particular substitutions of Lys29 and 
Lys32 yielded EF-P at least partially YmfI-independent and sufficient to restore swarming in 
the absence of YmfI.
To further characterize the YmfI-independent alleles of EF-P, each single mutant was 
introduced by allelic replacement at the native locus. Cells expressing EF-PK29N at the 
native site swarmed like the wild type and migrated as two bands on a semi-native gel (Fig 
2I, Fig 1C lane 5). The majority of the EF-PK29N resolved as the lower species, unlike wild 
type EF-P which resolved mostly as the upper species (Fig 1C, compare lane 1 to lane 5). 
One way in which the ratio of upper/lower bands could be altered in this way is if EF-PK29N 
affected the rate of post-translational modification. To test this hypothesis, translation was 
inhibited in an efpK29N mutant and EF-P electrophoretic mobility on a semi-native gel was 
monitored over time. The dominant EF-PK29N lower band appeared to decrease slowly with 
a concomitant increase in the intensity of the upper band indicative of a slow conversion of 
the oxidized to reduced modification (Fig 1A, right). Further, EF-PK29N expressed from the 
native site was not fully independent of YmfI as mutation of ymfI diminished swarming 
migration and abolished the faint upper band in semi-native gels (Fig 1C, compare lanes 5 
and 6; Fig 2I). We conclude that EF-PK29N has a decreased rate of post-translational 
modification thereby preventing accumulation of 5-aminopentanonated EF-P.
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Cells expressing EF-PK32R at the native site arrested swarming prematurely and resolved as 
a single band on native gels (Fig 1C lane 7; Fig 2J). Unlike efpK29N, mutation of ymfI did 
not diminish swarming migration of efpK32R or alter mobility on semi-native gel 
electrophoresis of the EF-PK32R protein (Fig 1C compare lanes 7 and 8; Fig 2J). Finally, 
wild type cells expressing the combined double mutant allele EF-PK29N,K32R exhibited a 
premature swarming arrest and resolved as a single band on native gels regardless of the 
presence of YmfI, similar to the EF-PK32R single mutant alone (Fig 1C compare lanes 9 and 
10; Fig 2K). We conclude that both lysine residues contribute to the same function as the 
phenotype of the double mutant was not additive, and that mutation of K32R yields EF-P 
YmfI-independent and is epistatic toK29N.
To determine the consequence of the suppressor mutations on post-translational EF-P 
modification, the EF-P alleles were fused to a FLAG tag, overexpressed, purified from B. 
subtilis, and analyzed by mass spectrometry. For the wild type and EF-PK29N protein, both 
unmodified and 5-aminopentanolylated EF-P were detected (Fig 4G–I). By contrast, only 
the unmodified fragment was detected for the EF-PK32R protein and no additional masses 
could be detected on the peptide (Fig 4J–L). We conclude that one way to bypass the need 
for YmfI and restore EF-P activity is to abolish EF-P modification on Lys32. We also 
conclude that cells mutated for ymfI exhibit a swarming defect because they accumulate an 
inhibitory 5-aminopentanone group on EF-P. Swarming inhibition may be relieved either by 
converting the group to 5-aminopentanol or by the accumulation of unmodified EF-P. 
Unmodified EF-P can accumulate by mutation of K32R, by decreasing the rate of post-
translation modification as seen in K29N mutants, or by simply overexpressing EF-P 
protein. Finally, we conclude that, to the best of our knowledge, B. subtilis EF-P is the only 
member of its family that functions in the absence of post-translational modification.
DISCUSSION
Elongation factor P is a highly conserved protein found in all domains of life that 
structurally resembles a tRNA, associates with the ribosome, and assists in translating 
particular primary sequences such as polyprolines (Blaha, 2009, Hanawa-Suetsugu, 2004, 
Schmidt, 2016, Doerfel, 2013, Ude, 2013, and Gutierrez, 2013). Furthermore, the EF-P 
position analogous to the site of amino acid attachment on tRNA is post-translationally 
modified by species-specific, structurally-divergent molecules (Lassak, 2016). Here we 
identify YmfI of Bacillus subtilis as the first protein shown to be involved in the post-
translational modification of EF-P by 5-aminopentanol. YmfI is a protein of previously 
unknown function that is a paralog of the fatty acid biosynthesis protein FabG and requires a 
conserved active site residue for its function (Fig S1). Furthermore, YmfI catalyzes the 
NADPH-dependent alteration of EF-P electrophoretic mobility in vitro and the reduction of 
EF-P 5-aminopentanone to 5-aminopentanol in vivo (Fig 7A). To date, B. subtilis is the only 
species known to modify EF-P with 5-aminopentanol but YmfI homologs were found by 
sequence analysis and synteny with upstream genes in the Firmicutes order of Bacilliales 
(Fig 3A,B). Based on our analyses, we predict that the genera of Listeria and 
Staphylococcus also modify EF-P with 5-aminopentanol.
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In Bacillus subtilis, EF-P is required for a flagellar-mediated form of surface motility called 
swarming and mutation of YmfI conferred a swarming defect. The swarming motility defect 
was not due to the inability to synthesize the mature 5-aminopentanol group and was rather 
due to the accumulation of the inhibitory oxidized 5-aminopentanone group as indicated by 
suppressor mutations that altered the EF-P primary sequence. One suppressor mutation 
changed the modified EF-P residue Lys32 to an arginine, and while the allele impaired 
swarming in a wild type cell, it bypassed the requirement for YmfI by abolishing 
modification altogether. Both a swarming impairment and lack of modification were 
previously reported in a site-directed mutation that changed Lys 32 to Ala (Rajkovic, 2016), 
but unlike the EF-PK32R allele, the EF-PK32A allele was unable to bypass the swarming 
requirement for YmfI. We infer that a positive charge at position 32 assists in the function of 
EF-P and that a lysine residue in particular is ideal in B. subtilis. The partial phenotypes of 
the EF-P K32R and K32A mutations however, indicate that 5-aminopentanolylation per se is 
not explicitly required for EF-P activity. To the best of our knowledge, the EF-P protein of 
B. subtilis is the first of its kind to retain substantial biological activity in the absence of 
post-translational modification possibly due to the below-expected number of genomic 
polyprolines encoded in B. sutilis (Rajkovic, 2016).
Another suppressor mutation changed the highly conserved EF-P residue Lys29 to an 
asparagine. EF-PK29N appears to reduce the rate of 5-aminopentanolylation on Lys32 as 
indicated by a dramatic reduction in upper EF-P band on semi-native gels. The lower band 
accumulated in the EF-PK29N mutant but could represent at least two different molecular 
species. 5-aminopentanonated EF-P resolves as the lower band as it was the only band 
observed in the absence of YmfI. The lower band also accumulated when EF-P was 
overexpressed, and unmodified EF-P predominated in mass spectrometry analyses. Thus, the 
lower band on semi-native gels may represent two molecular species, one in which Lys32 is 
unmodified and one in which Lys32 is 5-aminopentanonated. We infer that EF-PK29N 
restores swarming in the absence of YmfI by reducing the rate of post-translational 
modification thereby accumulating EF-P unmodified at Lys32. EF-P Lys29 could play a role 
in the catalysis of 5-aminopentanoylation as a binding site for modification proteins or as a 
residue for allosteric regulation. While we cannot distinguish whether Lys29 is an active or 
allosteric site, we note that Lys29 appears to be as highly conserved as Lys32 in EF-P 
proteins (Fig 7B, Fig S5).
Post-translational modification is thought to be essential for EF-P activity for the organisms 
in which it has been studied and is generally assumed to directly participate in the synthesis 
of certain primary sequences, but how the modification participates in potentiating 
translation is unknown. If the modification does directly participate in synthesis, it seems 
unusual that a conserved EF-P function can tolerate a wide variety of different chemical 
modifications including but likely not limited to lysine, hypusine, rhamnose, and 5-
aminopentanol groups depending on the organism. Furthermore, some modifications such as 
deoxyhypusine in the fungus Fusarium alter EF-P function and here we show in B. subtilis 
that 5-aminopentanonation has similar consequences, perhaps for regulatory reasons 
(Martinez-Rocha, 2016). Consistent with regulation, we show that in B. subtilis mutation of 
Lys32 to an Arg (a residue naturally found in other EF-P proteins; Fig 7B, Fig S5) partially 
preserves EF-P function in the absence of the 5-aminopentanol group. Moreover, 
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overexpression of EF-P and mutation of Lys29 to an asparagine results in the hyper-
accumulation of unmodified EF-P and bypasses the swarming defect caused by the absence 
of YmfI. Thus, we hypothesize an unmodified Lys32 may be fully functional in Bacillus 
subtilis. We speculate that post-translational modification of EF-P may serve a regulatory 
function in B. subtilis and perhaps other organisms.
Experimental Procedures
Strains and growth conditions
B. subtilis and E. coli strains were grown in lysogeny broth (LB) (10 g tryptone, 5 g yeast 
extract, 5 g NaCl per L) or on LB plates fortified with 1.5% Bacto agar at 37°C. When 
appropriate, antibiotics were included at the following concentrations: 10 μg/ml tetracycline, 
100 μg/ml spectinomycin, 5 μg/ml chloramphenicol, 5 μg/ml kanamycin, and 1 μg/ml 
erythromycin plus 25 μg/ml lincomycin (mls). Isopropyl β-D-thiogalactopyranoside (IPTG, 
Sigma) was added to the medium at the indicated concentration when appropriate.
For quantitative swarm assays, strains were grown to mid-log phase (OD600 0.3–1.0) 
concentrated to an OD600 of 10 in PBS pH 7.4 (0.8% NaCl, 0.02% KCl, 100 mM Na2HPO4, 
and 17.5 mM KH2PO4) plus 0.5% India ink. LB plates fortified with 0.7% agar were dried 
for 10 min open-faced in a laminar flow hood and subsequently inoculated by spotting 10 uL 
cell resuspensions onto the center of the plate. Plates were dried an additional 10 min open-
faced in a laminar flow hood and then incubated at 37°C in a humid chamber. Swarm radius 
was measured along the same axis every 30 minutes.
Images of swarm plates were obtained by toothpick-inoculating a colony into the center of 
an LB plate fortified with 0.7% agar. Plates were dried open-faced in a laminar flow hood 
for 12 min and incubated at 37°C in a humid chamber for 20 hrs. Images were taking using a 
BioRad Gel Doc.
Western Blotting
Strains were grown to mid-log phase, concentrated to an OD600 of 10 in lysis buffer (17.2 
mM Tris pH 7.0, 8.6 mM EDTA pH 8.0, 1 mg/mL Lysozyme, 0.1 mg/mL RNaseA, 20 
μg/mL DNase I, and 50 μg/mL phenylmethane sulfonyl fluoride) and incubated at 37°C for 
30 min. SDS sample buffer (500 mM Tris pH 6.8, 22% glycerol, 10% SDS, and 0.12% 
bromophenol blue) was added, and samples were boiled for 5 min. 12 μl boiled samples 
were loaded onto 10% polyacrylamide native (with no added SDS) or 15% polyacrylamide 
denaturing (with 0.1% SDS) gels. Lysates were resolved at 150 V for 1.25 hours, transferred 
onto nitrocellulose membranes, and subsequently probed with a 1:40,000 dilution of anti-
EF-P or a 1:80,000 dilution anti-SigA polyclonal antiserum. Following incubation with the 
primary antibodies, nitrocellulose membranes were probed with horseradish peroxidase 
conjugated goat anti-rabbit immunoglobulin G. Blots were developed using Pierce ECL 
substrate (Thermo Fisher Scientific). To inhibit translation, 200 ug/mL spectinomycin was 
added to mid-log phase cultures.
Hummels et al. Page 9
Mol Microbiol. Author manuscript; available in PMC 2018 October 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Strain construction
All constructs were introduced into DK1042, a competent derivative of ancestral strain 3610 
(Konkol et al., 2013) or laboratory strain PY79 and then transferred to the 3610 background 
using SPP1-mediated generalized phage transduction (Yasbin and Young, 1974). All strains 
used in this study are listed in Table 2. All plasmids used in this study are listed in 
Supplemental Table S1. All primers used in this study are listed in Supplemental Table S2.
Complementation constructs—To create the efp complementation construct, the PyqhS 
promoter was amplified using primers 477/478 and the efp gene was amplified using primers 
483/486 using B. subtilis 3610 genomic DNA as a template. Fragments were digested with 
EcoRI/XhoI and XhoI/BamHI respectively and subsequently ligated into the EcoRI and 
BamHI restriction sites of the plasmid pDG364, containing a polylinker and 
chloramphenicol resistance cassette between two arms of the amyE gene (Guérout-Fleury et 
al., 1996), to produce pDP85. pDP85 was transformed into DK2050 to produce DK3780. 
Site directed mutation of efp to change lysine 32 to an alanine was performed by amplifying 
DK3780 genomic DNA with primer pairs 3177/4039 and 3180/4038 (primers 4038 and 
4039 encode the efpK32A mutation). The resulting fragments were subjected to Gibson 
assembly (Gibson, 2009), and transformed into DK2050 followed by selection for 
chloramphenicol resistance to produce DK2248.
To create the ymfI complementation construct, the PymfF promoter was amplified using 
primers 4724/4884 and the ymfI gene was amplified using primers 4721/4722 using B. 
subtilis 3610 chromosomal DNA as a template. Fragments were digested with EcoRI/
HinDIII and HinDIII/NheI respectively were subsequently ligated into the EcoRI and NheI 
restriction sites of the plasmid pAH25, containing a polylinker and spectinomycin resistance 
cassette between two arms of the amyE gene, to produce pKRH50. pKRH50 was 
transformed into DK3621 followed by selection for spectinomycin resistance to produce 
DK3969. Site directed mutation of ymfI to change tyrosine 150 to an alanine was performed 
by amplifying DK3969 genomic DNA with primer pairs 4884/4971 and 4722/4970. The 
resulting fragments were subjected to Gibson assembly (Gibson, 2009) followed by PCR 
amplification by primers 4722/4884. The resulting DNA fragment was subsequently ligated 
into the EcoRI and NheI restriction sites of the plasmid pAH25 to produce pKRH67. 
Plasmid pKRH67 was transformed into DK3621 followed by selection on spec to produce 
DK4233.
Site directed mutation of the Physpank-efp-flag construct was performed by amplifying 
DK2448 genomic DNA (Rajkovic, 2015) with primer pairs 861/5133 and 862/5132 for 
efpK29N and 861/5143 861/5142 for efpK32R. Cognate fragments were subjected to Gibson 
assembly (Gibson, 2009) and transformed into DK2050 followed by selection for 
spectinomycin resistance to yield DK4246 and DK4247.
YmfI expression construct—To create the His-Sumo-YmfI expression construct, ymfI 
was amplified using primers 5439/5440 using B. subtilis 3610 chromosomal DNA as a 
template. The resulting fragment was digested with XhoI/SapI and subsequently ligated into 
the XhoI and SapI restriction sites of the plasmid pTB146 to produce pKRH76.
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Native site mutants—Site directed mutation of efp at the native site was performed by 
allelic replacement. 3610 genomic DNA was amplified using primer pairs 4031/5133 
4034/5132 for efpK29N, 4031/5143 4034/5042 for efpK32R, and 4031/5145 4034/5144 for 
efpK29N,K32R. Cognate fragments were introduced into the SmaI restriction site of 
pMiniMAD using Gibson assembly (Patrick and Kearns, 2008; Gibson, 2009) to produce 
pKRH59, pKRH60, and pKRH61 which were subsequently passaged through the recA+ 
Escherichia coli strain TG1 and transformed into DK1042. Plasmid pMiniMAD (and its 
derivatives pKRH59, pKRH60, and pKRH61) encodes an mls resistance cassette and a 
temperature sensitive origin that is active at room temperature but not at 37°C. Thus, mls-
resistant colonies were isolated at 37°C (ensuring integration of the plasmid into the 
chromosome) and subsequently grown in overnight at room temperature, thereby activating 
the plasmid-encoded temperature sensitive origin and inciting plasmid excision. Mls-
sensitive colonies were isolated and the efp locus was sequenced to determine the allele 
present at that site.
Random mutagenesis of efp—Mutagenesis of the efp complementation construct was 
achieved by amplification of DK3789 genomic DNA with primer pair 4891/3180 using the 
error prone Taq polymerase (New England BioLabs Inc.). To decrease the frequency of 
obtaining mutations that increase expression of EF-P through altering its promoter, the 
portion of the complementation construct upstream of efp (including PyqhS) was amplified 
with primers 3177/4892 using the high fidelity Phusion polymerase (New England BioLabs 
Inc.). The two fragments were ligated together using Gibson assembly (Gibson, 2009) and 
the products subsequently PCR amplified with primers 954/3180. The resulting 7 pools of 
mutagenized amyE∷PyqhS-efp were transformed into DK2886 and chloramphenicol-resistant 
colonies were selected.
Approximately 1700 colonies for each of 7 pools were scraped off of selection plates as a 
mixture, diluted into LB, and grown to mid-log phase at 37°C. Cell mixtures were then 
subjected to swarm assays as described above. Following a 9–10 hour incubation on swarm 
plates, swarming-competent cells began to emerge from the site of inoculation and one 
colony per pool was isolated from the edge of the swarm front. The amyE∷PyqhS-efp 
complementation construct from each of the ymfI suppressors was backcrossed into 
DK2886 by SPP1-mediated transduction and the retention of swarming motility was 
confirmed. For each ymfI suppressor, the efp complementation construct was sequenced to 
determine the mutations present.
Insertion/deletion mutants
ymfF∷tet: Mutation of ymfF was performed by amplifying the regions upstream (with 
primers 4788/4789) and downstream (with primers 4790/4791) of ymfF using 3610 
chromosomal DNA as a template, and amplifying the tetracycline resistance cassette from 
pDG1515 with primers 3250/3251 (Guérout-Fleury, 1995). The three fragments were ligated 
by Gibson assembly and transformed into DK1042 to produce DK3726. The mutation was 
confirmed by PCR length polymorphism analysis.
Hummels et al. Page 11
Mol Microbiol. Author manuscript; available in PMC 2018 October 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
ymfH∷tet: Mutation of ymfH was performed by amplifying the regions upstream (with 
primers 4792/4793) and downstream (with primers 4832/4795) of ymfH using 3610 
chromosomal DNA as a template, and amplifying the tetracycline resistance cassette from 
pDG1515 with primers 3250/3251. The three fragments were ligated using Gibson assembly 
and transformed into DK1042 to produce DK3727. The mutation was confirmed by PCR 
length polymorphism analysis.
ymfFH∷tet: Simultaneous mutation of ymfF and ymfH was performed by amplifying the 
regions upstream of ymfF (with primers 4788/4789) and downstream of ymfH (with primers 
4832/4795) using 3610 chromosomal DNA as a template, and amplifying the tetracycline 
resistance cassette from pDG1515 with primers 3250/3251. The three fragments were 
ligated using Gibson assembly and transformed into DK1042 to produce DK3727. The 
mutation was confirmed by PCR length polymorphism analysis.
ymfJ∷tet: Mutation of ymfJ was performed by amplifying the regions upstream (with 
primers 105/106) and downstream (with primers 107/108) of ymfJ using 3610 chromosomal 
DNA as a template, the fragments were purified and used to amplify the tetracycline 
resistance cassette from HaeII-digested pDG1515. The amplification product was used as a 
template to cement the fragment using primers 105/108. The final long-flanking homology 
disruption cassette (Wach, 1996) was transformed into laboratory strain PY79 and 
transduced to 3610 by SPP1-mediated phage transduction to produce DS236. The mutation 
was confirmed by PCR length polymorphism analysis.
ΔyqhS: Deletion of yqhS was achieved through allelic replacement. 3610 genomic DNA 
was amplified using primer pairs 4023/4024 and 4025/4026 and the resulting fragments 
were introduced into the SmaI restriction site of pMiniMAD using Gibson assembly 
(Gibson, 2009) to produce pKRH1. Plasmid pKRH1 was passaged through the recA+ 
Escherichia coli strain TG1, transformed into DK1042, integrated by selecting mls resistant 
colonies at 37°C and evicted by passage at room temperature. Mls-sensitive colonies were 
isolated and confirmed to encode the deletion by PCR length polymorphism analysis.
ΔpapA: Deletion of papA was achieved through allelic replacement. 3610 genomic DNA 
was amplified using primer pairs 4027/4028 and 4029/4030 and the resulting fragments 
were introduced into the SmaI restriction site of pMiniMAD using Gibson assembly 
(Gibson, 2009) to produce pKRH2. Plasmid pKRH2 was passaged through the recA+ 
Escherichia coli strain TG1, transformed into DK1042, integrated by selecting mls resistant 
colonies at 37°C and evicted by passage at room temperature. Mls-sensitive colonies were 
isolated and confirmed to encode the deletion by PCR length polymorphism analysis.
SPP1-mediated transduction—SPP1-mediated transductions were performed as 
described previously (Yasbin, 2004). In short, lysates were created on B. subtilis strains 
grown in TY (1% Tryptone, 0.5% yeast extract, 0.5% NaCl, 10mM MgSO4, and 1mM 
MnSO4). Recipient strains were grown in TY to stationary phase, 1 mL diluted into 9 mL 
TY, and 10 μL (for tetracycline selection) or 25 μL (for spectinomycin and chloramphenicol 
selection) lysates were added, followed by incubation at room temperature for 30 min and 
selection for the respective antibiotic resistance at 37°C overnight. For transductions in 
Hummels et al. Page 12
Mol Microbiol. Author manuscript; available in PMC 2018 October 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
which spectinomycin or chloramphenicol-resistance was selected for, 10 mM sodium citrate 
was added to the selection plates.
Mass Spectrometry
Flag-tagged EF-P was overexpressed and purified from each mutant strain (DK2448, 
DK3828, DK4246, and DK4247) as previously described (Rajkovic, 2016). Following 
purification, the eluate was concentrated and resolved on a 13% SDS-PAGE gel. Protein was 
visualized with colloidal Coomassie, excised from the gel, and in-gel digested with 
chymotrypsin. The generated peptide samples were brought up in 2% acetonitrile in 0.1% 
formic acid (20 μL) and analyzed (4 μL) by LC/ESI MS/MS with a Thermo Scientific Easy-
nLC II (Thermo Scientific, Waltham, MA) coupled to a hybrid Orbitrap Elite ETD (Thermo 
Scientific, Waltham, MA) mass spectrometer using an instrument configuration as described 
(Yi et al). In-line de-salting was accomplished using a reversed-phase trap column (100 μm 
× 20 mm) packed with Magic C18AQ (5-μm 200Å resin; Michrom Bioresources, Auburn, 
CA) followed by peptide separations on a reversed-phase column (75 μm × 250 mm) packed 
with Magic C18AQ (5-μm 100Å resin; Michrom Bioresources, Auburn, CA) directly 
mounted on the electrospray ion source. A 40-minute gradient from 2% to 40% acetonitrile 
in 0.1% formic acid at a flow rate of 400 nL/minute was used for chromatographic 
separations. A spray voltage of 2750 V was applied to the electrospray tip and the Orbitrap 
Elite instrument was operated in the data-dependent mode, switching automatically between 
MS survey scans in the Orbitrap (AGC target value 1,000,000, resolution 120,000, and 
injection time 250 milliseconds) with MS/MS spectra detected in the Orbitrap (AGC target 
value of 50,000, 15,000 resolution and injection time 250 milliseconds). The 3 most intense 
ions from the Fourier-transform (FT) full scan were selected for fragmentation in the 
Orbitrap using ETD 100 ms activation time with supplemental CID activation with 
normalized collision energy of 35%. Selected ions were dynamically excluded for 10 
seconds.
Isotope Distribution Analysis—Predicted isotope distributions were calculated using 
the Scientific Instrument Services, Inc. Isotope Distribution Calculator and Mass Spec 
Plotter. Actual abundances of each ion were quantified using Thermo Xcalibur software with 
a Genesis peak picking algorithm and an m/z range of 0.02. To compare the predicted and 
actual distributions, the measured abundances were set relative to the most abundant ion for 
the peptide with the indicated modification.
Phylogenetic Analyses
All phylogenetic trees are presented using the Interactive Tree of Life visualization software 
(Letunic, 2016). To identify the conservation of the different EF-P post-translational 
modification systems and B. subtilis EF-P residues 29 and 32 (analogous to residues 31 and 
34 respectively in E. coli) across all domains of life, the genomes of 191 organisms 
identified by Ciccarelli, et al. were annotated with the Pfam 29 library using the software 
hmmer v 3.1b2 and an E value threshold of 1e-5 (Ciccarelli, 2006; Finn, 2016; Eddy, 1998). 
The presence of EarP was established by the annotation of a DUF2331 domain and the 
presence of DHS was established by the annotation of a DS domain. The presence of EpmA 
was established by the annotation of a protein that contained a tRNA-synt_2 domain with 
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homology beginning at residue 15–30 of the profile hidden Markov model (HMM) and 
without a tRNA_anti-codon domain. The presence of YmfI was established by the presence 
of 3 co-oriented open reading frames separated by no more than 500 bp that encode proteins 
with domains found in the YmfFHI proteins. Specifically, YmfF and YmfH were identified 
by the presence of Peptidase_M16 or Peptidase_M16_C domains, and YmfI homologs were 
identified by the presences of adh_short or adh_shortC2 domains.
To identify EF-P and eIF5a homologs, proteins that most closely aligned to the eIF-5a, 
EFP_N, EFP, or Elongation-fact-P_C were identified and subsequently aligned to the 
EFP_N domain. The identity of EF-P residue 32 was determined by the residue aligning to 
position 30 of the EFP_N profile HMM and the identity of EF-P residue 29 was determined 
by the residue aligning to position 27 of the EFP_N profile HMM.
To gain further clarity on which bacteria are likely to encode a YmfI homolog and thereby 5-
aminopentanolylated EF-P, all species taxIDs with a completed bacterial genome available 
on the NCBI reference sequence database were analyzed for the presence of a YmfFHI 
operon structure as described above.
In vitro Reactions—The His-Sumo-YmfI expression construct, pKRH76, was 
transformed into E. coli Rosetta gami cells and grown in Terrific broth (12 g tryptone, 24 g 
yeast extract, 4 mL glycerol, 2.31 g monobasic potassium phosphate and 12.54 g dibasic 
potassium phoasphate) to mid-log phase. 1 mM IPTG was then added and the culture was 
grown overnight at 16°C. Cells were pelleted, resuspended in lysis buffer (50 mM 
Na2HPO4, 300 mM NaCl, and 10 mM imidazole) and lysed by sonication. Cell debris was 
pelleted by centrifugation at 31,000 × g for 30 min and Ni-nitrolotriacetic acid resin 
(Novagen) was added to the clarified supernatant. The bead-lysate mixture was incubated at 
4°C overnight. Beads were sedimented, the supernatant was removed, and the beads were 
washed 3 times with wash buffer (50 mM Na2HPO4, 300 mM NaCl, and 30 mM 
imidazole). Beads were resuspended in wash buffer, applied to a 1-cm separation column 
(Bio-Rad), and His-SUMO-YmfI was eluted with wash buffer containing 250 mM 
imidazole. To cleave the His-SUMO tag from the purified YmfI, ubiquitin ligase/protease 
was added and the reaction was incubated at 4°C overnight. To remove the free His-SUMO 
and any remaining His-SUMO-YmfI from the cleavage reaction, Ni-nitrolotriacetic acid 
resin (Novagen) was added and incubated at 4°C for 1 hr. Beads were pelleted by 
centrifugation and the supernatant, containing untagged YmfI, was dialyzed into PBS pH 7.4 
plus 50% glycerol and stored at 4°C. EF-PymfI-FLAG was purified from DK3828 as 
described previously (RajKovic, 2016).
10 μL reactions containing 5 μg EF-PymfI-FLAG was incubated in 100 mM sodium 
phosphate buffer at 37°C for 30 min. 4 μg YmfI with or without 150 μM NADPH was added 
to the reaction, where appropriate. Reactions were stopped by the addition of 50% glycerol, 
resolved by native gel electrophoresis, electroblotted, and probed with anti-EF-P polyclonal 
antisera.
Hummels et al. Page 14
Mol Microbiol. Author manuscript; available in PMC 2018 October 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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SUMMARY
Elongation factor P (EF-P) is found in all living things and helps ribosomes translate 
proline rich sequences. Moreover, EF-P is modified with different chemical groups 
depending on the organism and modification is thought to be essential for activity. Here 
we find the first protein, YmfI, involved in modification of B. subtilis EF-P with 5-
aminopentanol and show that, in the absence of YmfI, an inhibitory intermediate 
accumulates. Further, we show that EF-P biological activity can be restored to cells 
lacking YmfI by by specific mutations that reduce or abolish modification, suggesting 
that the presence of the modification may be regulatory. Phylogenetic analysis suggests 
that EF-P may be similarly modified in Listeria and Staphylococcus.
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Figure 1. EF-P resolves as two species on a semi-native gel in a YmfI-dependent manner
(A) Translation was inhibited in mid-log phase cultures by the addition of spectinomycin, 
lysates were subsequently harvested at the indicated time points, resolved by semi-native 
(top panel, “SN”) or denaturing (middle and bottom panels) polyacrylamide gel 
electrophoresis, electroblotted, and probed with anti-EF-P or anti-SigA polyclonal antisera 
(used as a loading control) as indicated. The following strains were used to generate the 
samples: wild type (DK1042), ymfI (DK3621), and efpK29N (DK4282). For denaturing gels, 
EF-P resolved at approximately 22 kDa and SigA resolved at approximately 46 kDa. The 
black arrow indicates the upper band and the white arrow indicates the lower band. (B) 
Lysates of mid-log phase cultures were resolved by semi-native (top panel, “SN”) or 
denaturing (middle and bottom panels) polyacrylamide gel electrophoresis, electroblotted, 
and probed with anti-EF-P or anti-SigA polyclonal antisera as indicated. The following 
strains were used to generate the samples: wild type (3610), cheC (DS1045), cheD 
(DS1064), comP (DS1028), efp (DS1124), flhG (DS1164), rrnB-16S (DS1146), srfAA 
(DS1102), srfAB (DS1044), srfAC (DS1122), swrA (DS1026), swrB (DS1107), swrC 
(DS1113), yabR (DS1078), and ymfI (DS1029) (C) Lysates of mid-log phase cultures were 
resolved by semi-native (top panel, “SN”) or denaturing (middle and bottom panels) 
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polyacrylamide gel electrophoresis, electroblotted, and probed with anti-EF-P or anti-SigA 
polyclonal antisera as indicated. Lanes are numbered at the bottom of the panels for clarity 
in text. The presence and absence of a wild type copy of the ymfI gene is indicated by (+) 
and (-) respectively at the top of the panels. The following strains were used to generate 
samples: wild type (DK1042), ymfI (DK3621), efpK32A (DK3235), efpK32A ymfI 
(DK3712), efpK29N (DK4282), efpK29N ymfI (DK4396), efpK32R (DK4359), efpK32R ymfI 
(DK4397), efpK29N,K32R (DK4420), and efpK32A,K32R ymfI (DK4436). (D) EF-P-FLAG 
purified from a ymfI mutant (EF-P-FLAGymfI) was incubated alone, with YmfI, or with 
YmfI and 150 mM NADPH for 30 min at 37C. Reactions were subsequently resolved by 
semi-native gel electrophoresis, electroblotted, and probed with anti-EF-P antisera. (E) 
Lysates of mid-log phase cultures were resolved by semi-native (top panel, “SN”) or 
denaturing (middle and bottom panels) polyacrylamide gel electrophoresis, electroblotted, 
and probed with anti-EF-P or anti-SigA polyclonal antisera as indicated. The following 
strains were used to generate the samples: wild type (DK1042), efp (efp) (DK3780), ymfI 
(DK3621), ymfI efp (efp) (DK3789), efpK32A (DK3235), efp (efpK32A) (DK2248), efpK29N 
(DK4282), efp (efpK29N) (DK4043), efpK32R (DK4359), efp (efpK32R) (DK4072).
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Figure 2. Cells mutated for ymfI are defective in swarming motility and swarming can be 
restored by mutations in efp
(A) Top views of centrally-inoculated swarm plates incubated overnight at 37°C were 
imaged against a black background. Zones of colonization appear light grey. The plate 
inoculated with the ymfI mutant has internal rings that mark the locations at which the 
population stopped moving and restarted at a later time point. Note: a comparable cessation 
can be seen at hour 5 in the quantitative swarm expansion assay in panel 2B. The following 
strains were used to generate the panels: wild type (DK1042), efp (DK2050), ymfI 
(DK3621), efpK32A (DK3235), and ymfI efpK32A (DK3712).(B-K) Quantitative swarm 
expansion assays in which mid-log phase cultures were concentrated and used to inoculate 
swarm plates. Swarm expansion was monitored along the same axis every 30 min for 5–6 
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hours. Each data point represents the average of three replicates and error bars represent the 
standard deviation. The following strains were used as the inoculum (B) wild type 
(DK1042), efp (DK2050), and ymfI (DK3621). (C) efpK32A (DK3235) and efpK32A ymfI 
(DK3712). (D) ymfI (ymfIY150A) (DK4233), ymfI (ymfI) (DK3969), and ymfI (DK3621). 
(E) efp (DK2050) and efp (efp) (DK3780). (F) efp ymfI (DK2886), and efp ymfI (efp) 
(DK3789). (G) efp ymfI (efp) DK3789, efp ymfI (efpK29N) (DK4043), and, efp ymfI 
(efpK32R) (DK4072). (H) efp ymfI (efp) (DK3789) and efp ymfI (efpK32A) (DK2889). (I) 
efpK29N (DK4282), efpK29N ymfI (DK4396), and ymfI (DK3621). (J) efpK32R (DK4359), 
efpK32R ymfI (DK4397), and ymfI (DK3621). (K) efpK29N,K32R (DK4420), efpK29N,K32R 
ymfI (DK4436), and ymfI (DK3621).
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Figure 3. Genetic architecture and phylogenetic distribution of the ymfI locus
(A) Predicted genetic architecture of the ymfI locus and the design of the PymfF-ymfI 
complementation construct. Both ymfF and ymfH are predicted to encode peptidases and 
ymfJ encodes a DUF3235-domain containing protein. (B) The distribution of homologs of 
the EF-P modification enzymes deoxyhypusine synthase, DHS (dark blue), EpmA (light 
blue), EarP (yellow), and YmfI (red) across the three domains of life. YmfI is a member of 
the large family of alcohol dehydrogenases and the proximity to neighboring genes as 
indicated in Fig 3A was used to aid in the identification of YmfI homologs. Where multiple 
enzymes are encoded in the same genome, the bar is split accordingly. White space indicates 
the absence of a homolog to any EF-P modification enzyme. Numbers indicate the following 
clades (1) Flavobacterium-Cytophaga-Bacteroides group, (2) Chlamydiales, (3) 
Planctomycetes, (4) Spirochaetes, (5) Actinobacteria, (6) Deinococcus-Thermus group, and 
(7) Cyanobacteria. Bacillus subtilis is highlighted in pink. See Fig S5 enlarged map with 
species names. Table S3 contains the accession numbers for each species and Table S4 
contains all sequences called to be YmfI in all completed bacterial genomes to date.
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Figure 4. Deletion of ymfI results in 5-aminopentanonation of EF-P and can be suppressed by 
abolishing EF-P post-translational modification
Extracted ion chromatograms of chymotrypsin-digested EF-P peptide from wild type (A–C), 
ymfI mutant (D–F), efpK29N mutant (G–I), and efpK32R mutant (J–L). Three different 
species were detected for the peptide corresponding to the wild type sequence 
QHVKPGKGAAF containing including unmodified (A,D,G,J), 5-aminopentanolylated 
(B,E,H,K), and 5-aminopentanonated (C,F,I,L) lysine residue 32. All chromatograms for 
ymfI represent the 2+ ion for the indicated peptide. All other chromatograms represent the 
3+ ion for the indicated peptide. Point mutations are indicated in bold red lettering. 
Predicted chemical structures are indicated. The cartoon indicates that the hydroxyl/carbonyl 
group is at the C3 position but it is possible that the hydroxyl group is at the C4 position 
instead. The precise position of the carbonyl can only be unequivocally determined with the 
use NMR or other high resolution structural methods.
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Figure 5. EF-P is 5-aminopentanonated in the absence of YmfI
MS2 spectrum generated from ETD fragmentation of the QHVKPGKGAAF peptide. Both 
(A) Unmodified (precursor m/z of 570.320) and (B) 5-aminopentanonated (precursor m/z of 
413.752) peptide were detected in the absence of ymfI. z ions are indicated in blue, and c 
ions are indicated in green. Site of 5-aminopentanonation (Lys32) is marked in red.
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Figure 6. Overexpression of EF-P results in hyper-accumulation of the unmodified form and 
partially bypasses the need for YmfI
A) An efp mutant and B) a efp ymfI double mutant each with an ectopically integrated 
Physpank-EF-P-FLAG construct was induced with the indicated concentrations of IPTG and 
measured for swarming motility radius after 4 hours of incubation (upper panel) and 
Western blot analysis following semi-native gel (SN) (top row) and denaturing (middle and 
bottom rows) electrophoresis of cell lystates (lower panel). Note, dashed line on 4 hr swarm 
expansion graph indicates the extent of expansion of either wild type (A) or a ymfI mutant 
(B). The following strains were used to generate samples: efp Physpank-efp-flag (DK2448) 
and efp ymfI Physpank-efp-flag (DK3828). Wild type (DK1042) and ymfI (DK3621) were 
used to generate the dashed lines.
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Figure 7. Model of EF-P activation by YmfI
(A) The crystal structure of EF-P isolated from the close relative of B. subtilis, Clostridium 
thermocellum (PDB ID 1YBY) with the location of Lys 29 (K29) and Lys 32 (K32) 
indicated. YmfI catalyzes the converstion of 5-aminopentanone (left) to 5-aminopentanol 
(right) groups on Lys32. In the absence of YmfI, 5-aminopentanone accumulates on EF-P 
and inhibits swarming motility (T-bar). (B) A multiple sequence alignment of EF-P 
orthologs from B. subtilis (Bsu), C. thermocellum (Cth), E. coli (Eco), Pseudomonas 
aeruginosa (Pae), Thermus thermophilus (Tth), the archaeon Haloferax volcanii (Hvo), and 
the eukaryote Homo sapiens (Hsa). The location of B. subtilis EF-P conserved residues K29 
and K32 are indicated by carets.
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Table 1
Mutations in efp that improve swarming in the absence of YmfI
Strain Number Genotype Nucleotide substitution(s)
DK4043 efpK29N AAA > AAT (residue 29)
DK4978 efpK29N AAA > AAT (residue 29)
DK4072 efpK32R AAA > AGG (residue 32)
DK4075 efpK32R,E101V AAA > AGA (residue 32) GAA > GTA (residue 101)
DK4076 efpK32R,V111M AAA > AGA (residue 32) GTG > ATG (residue 111)
DK4073 efpK32R,E124G AAA > AGA (residue 32) GAA > GGA (residue 124)
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Table 2
Strains
Strain Genotype Reference
3610 Wild type
DK1042 comIQ12L Konkol, 2013
DK1962 comIQ12L ΔyqhS
DK2050 comIQ12L Δefp Rajkovic, 2016
DK2248 comIQ12L Δefp amyE∷PyqhS-efpK32A cat
DK2448 comIQ12L Δefp amyE∷Physpank-efp-flag spec Rajkovic, 2016
DK2886 comIQ12L Δefp ymfI∷tet
DK2889 comIQ12L Δefp ymfI∷tet amyE∷PyqhS-efpK32A cat
DK3159 comIQ12L ΔpapA
DK3235 comIQ12L efpK32A Rajkovic, 2016
DK3621 comIQ12L ymfI∷tet
DK3712 comIQ12L efpK32A ymfI∷tet
DK3726 comIQ12L ymfF∷tet
DK3727 comIQ12L ymfH∷tet
DK3728 comIQ12L ymfFH∷tet
DK3780 comIQ12L Δefp amyE∷PyqhS-efp cat
DK3789 comIQ12L Δefp ymfI∷tet amyE∷PyqhS-efp cat
DK3828 comIQ12L Δefp ymfI∷tet amyE∷Physpank-efp-flag spec
DK3969 comIQ12L ymfI∷tet amyE∷PymfF-ymfI spec
DK4043 comIQ12L Δefp ymfI∷tet amyE∷PyqhS-efpK29N cat
DK4072 comIQ12L Δefp ymfI∷tet amyE∷PyqhS-efpK32R cat
DK4073 comIQ12 L Δefp ymfI∷tet amyE∷PyqhS-efpK32R,E124G cat
DK4075 comIQ12 L Δefp ymfI∷tet amyE∷PyqhS-efpK32R,E101V cat
DK4076 comIQ12L Δefp ymfI∷tet amyE∷PyqhS-efpK32R,V111M cat
DK4233 comIQ12L ymfI∷tet amyE∷PymfF-ymfIY150A spec
DK4246 comIQ12L Δefp amyE∷Physpank-efpK29N-flag spec
DK4247 comIQ12L Δefp amyE∷Physpank-efpK32R-flag spec
DK4282 comIQ12L efpK29N
DK4359 comIQ12L efpK32R
DK4396 comIQ12L efpK29N ymfI∷tet
DK4397 comIQ12L efpK32R ymfI∷tet
DK4420 comIQ12L efpK29N,K32R
DK4436 comIQ12L efpK29N,K32R ymfI∷tet
DS235 ymfI∷tet Kearns, 2004
DS236 ymfJ∷tet
DS1026 swrA∷Tn10 spec Kearns, 2004
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Strain Genotype Reference
DS1028 comP∷Tn10spec Kearns, 2004
DS1029 ymfI∷Tn10spec Kearns, 2004
DS1044 srfAB∷Tn10spec Kearns, 2004
DS1045 cheC∷Tn10spec Kearns, 2004
DS1064 cheD∷Tn10spec Kearns, 2004
DS1078 yabR∷Tn10spec Kearns, 2004
DS1102 srfAA∷Tn10spec Kearns, 2004
DS1107 swrB∷Tn10spec Kearns, 2004
DS1113 swrC∷Tn10spec Kearns, 2004
DS1122 srfAC∷Tn10spec Kearns, 2004
DS1124 efp∷Tn10spec Kearns, 2004
DS1146 rrnB∷Tn10spec Kearns, 2004
DS1164 flhG∷Tn10spec Kearns, 2004
PY79 sfp0 swrA
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